Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats

Clinical Science

Volumn 125, Issue 7, 2013, Pages 349-359

  Elmarakby, Ahmed A ^a,b   Faulkner, Jessica ^a   Pye, Chelsey ^a   Rouch, Katelyn ^a   Alhashim, Abdulmohsin ^a   Maddipati, Krishna Rao ^c   Baban, Babak ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; Diabetic renal injury; Haem oxygenase; Inflammation; Soluble epoxide hydrolase (SEH)

Indexed keywords

ALBUMIN; EPOXIDE HYDROLASE; FIBRONECTIN; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; EXTRACELLULAR MATRIX; GLOMERULAR FILTRATION BARRIER; GLUCOSE BLOOD LEVEL; KIDNEY CORTEX; KIDNEY FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SPONTANEOUSLY HYPERTENSIVE RAT;

ACTINS; ALBUMINURIA; ANIMALS; BENZOATES; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; EPOXIDE HYDROLASES; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KIDNEY CORTEX; MALE; MEMBRANE PROTEINS; METALLOPORPHYRINS; RATS; RATS, INBRED SHR; UREA;

EID: 84880115866     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130003     Document Type: Article

References (47)

1. Rivero, A., Mora, C., Muros, M., Garcia, J., Herrera, H. and Navarro-Gonzalez, J. F. (2009) Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin. Sci. (Lond.) 116, 479-492
2. Rossing, P. (2006) Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49, 11-19
3. Trimarchi, H., Muryan, A., Dicugno, M., Young, P., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Rana, M. S. and Alonso, M. (2012) Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis. Int. J. Nephrol. Renovasc. Dis. 5, 1-7
4. Yamagishi, S. (2011) Cardiovascular disease in recent onset diabetes mellitus. J. Cardiol. 57, 257-262
5. Elmarakby, A. A. (2012) Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. Am. J. Physiol. Regul. Integr. Comp. Physiol 302, R321-R330
6. Sasser, J. M., Sullivan, J. C., Hobbs, J. L., Yamamoto, T., Pollock, D. M., Carmines, P. K. and Pollock, J. S. (2007) Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J. Am. Soc. Nephrol. 18, 143-154
7. Elmarakby, A. A., Faulkner, J., Baban, B., Saleh, M. A. and Sullivan, J. C. (2012) Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 302, F791-F800
8. Imig, J. D. and Hammock, B. D. (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discovery 8, 794-805
9. Elmarakby, A. A., Faulkner, J., Al-Shabrawey, M., Wang, M. H., Maddipati, K. R. and Imig, J. D. (2011) Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1307-R1317
10. Cao, J., Drummond, G., Inoue, K., Sodhi, K., Li, X. Y. and Omura, S. (2008) Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress. Int. J. Mol. Sci. 9, 2388-2406
11. Hou, X., Shen, Y. H., Li, C., Wang, F., Zhang, C., Bu, P. and Zhang, Y. (2010) PPAR agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity. Biochem. Biophys. Res. Commun. 394, 653-659
12. Elmarakby, A. A., Faulkner, J., Posey, S. P. and Sullivan, J. C. (2010) Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats. Pharmacol. Res. 62, 400-407
13. Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J., Pollock, D. M., Newman, J. W., Kim, I. H., Watanabe, T. and Hammock, B. D. (2005) An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46, 975-981
14. Zhao, X., Yamamoto, T., Newman, J. W., Kim, I. H., Watanabe, T., Hammock, B. D., Stewart, J., Pollock, J. S., Pollock, D. M. and Imig, J. D. (2004) Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 15, 1244-1253
15. Honetschlagerova, Z., Sporkova, A., Kopkan, L., Huskova, Z., Hwang, S. H., Hammock, B. D., Imig, J. D., Kramer, H. J., Kujal, P., Vernerova, Z. et al. (2011) Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats. J. Hypertens. 29, 1590-1601
16. Manhiani, M., Quigley, J. E., Knight, S. F., Tasoobshirazi, S., Moore, T., Brands, M. W., Hammock, B. D. and Imig, J. D. (2009) Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am. J. Physiol. Renal Physiol. 297, F740-F748
17. Chen, G., Xu, R., Wang, Y., Wang, P., Zhao, G., Xu, X., Gruzdev, A., Zeldin, D. C. and Wang, D. W. (2012) Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am. J. Physiol. Endocrinol. Metab. 303, E563-E575
18. Luo, P., Chang, H. H., Zhou, Y., Zhang, S., Hwang, S. H., Morisseau, C., Wang, C. Y., Inscho, E. W., Hammock, B. D. and Wang, M. H. (2010) Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J. Pharmacol. Exp. Ther. 334, 430-438
19. Luria, A., Bettaieb, A., Xi, Y., Shieh, G. J., Liu, H. C., Inoue, H., Tsai, H. J., Imig, J. D., Haj, F. G. and Hammock, B. D. (2011) Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 108, 9038-9043
20. Iyer, A., Kauter, K., Alam, M. A., Hwang, S. H., Morisseau, C., Hammock, B. D. and Brown, L. (2012) Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp. Diabetes Res. 2012, 758614
21. Yu, Z., Xu, F., Huse, L. M., Morisseau, C., Draper, A. J., Newman, J. W., Parker, C., Graham, L., Engler, M. M., Hammock, B. D. et al. (2000) Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 87, 992-998
22. Seubert, J. M., Xu, F., Graves, J. P., Collins, J. B., Sieber, S. O., Paules, R. S., Kroetz, D. L. and Zeldin, D. C. (2005) Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 289, F552-F561
23. Jiang, H., Quilley, J., Doumad, A. B., Zhu, A. G., Falck, J. R., Hammock, B. D., Stier, Jr, C. T. and Carroll, M. A. (2011) Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 300, H1990-H1996
24. Koeners, M. P., Wesseling, S., Ulu, A., Sepulveda, R. L., Morisseau, C., Braam, B., Hammock, B. D. and Joles, J. A. (2011) Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am. J. Physiol. Endocrinol. Metab. 300, E691-E698
25. Olearczyk, J. J., Quigley, J. E., Mitchell, B. C., Yamamoto, T., Kim, I. H., Newman, J. W., Luria, A., Hammock, B. D. and Imig, J. D. (2009) Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin. Sci. 116, 61-70
26. Sacerdoti, D., Bolognesi, M., Di Pascoli, M., Gatta, A., McGiff, J. C., Schwartzman, M. L. and Abraham, N. G. (2006) Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. Am. J. Physiol. Heart Circ. Physiol. 291, H1999-H2002
27. Sacerdoti, D., Colombrita, C., Di Pascoli, M., Schwartzman, M. L., Bolognesi, M., Falck, J. R., Gatta, A. and Abraham, N. G. (2007) 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostaglandins Other Lipid Mediat. 82, 155-161
28. Sodhi, K., Inoue, K., Gotlinger, K. H., Canestraro, M., Vanella, L., Kim, D. H., Manthati, V. L., Koduru, S. R., Falck, J. R., Schwartzman, M. L. et al. (2009) Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J. Pharmacol. Exp. Ther. 331, 906-916
29. Sodhi, K., Puri, N., Inoue, K., Falck, J. R., Schwartzman, M. L. and Abraham, N. G. (2012) EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat. 98, 133-142
30. da Silva, J. L., Zand, B. A., Yang, L. M., Sabaawy, H. E., Lianos, E. and Abraham, N. G. (2001) Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int. 59, 1448-1457
31. Li, M., Kim, D. H., Tsenovoy, P. L., Peterson, S. J., Rezzani, R., Rodella, L. F., Aronow, W. S., Ikehara, S. and Abraham, N. G. (2008) Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57, 1526-1535
32. Matsumoto, M., Makino, Y., Tanaka, T., Tanaka, H., Ishizaka, N., Noiri, E., Fujita, T. and Nangaku, M. (2003) Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J. Am. Soc. Nephrol. 14, 1825-1832
33. Yang, Z. Z., Zhang, A. Y., Yi, F. X., Li, P. L. and Zou, A. P. (2003) Redox regulation of HIF-1 levels and HO-1 expression in renal medullary interstitial cells. Am. J. Physiol. Renal Physiol. 284, F1207-F1215
34. Yang, Z. Z. and Zou, A. P. (2001) Transcriptional regulation of heme oxygenases by HIF-1 in renal medullary interstitial cells. Am. J. Physiol. Renal Physiol. 281, F900-F908
35. Liu, M. and Alkayed, N. J. (2005) Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1-linked induction of P450 2C11 epoxygenase in astrocytes. J. Cereb. Blood Flow Metab. 25, 939-948
36. Suzuki, S., Oguro, A., Osada-Oka, M., Funae, Y. and Imaoka, S. (2008) Epoxyeicosatrienoic acids and/or their metabolites promote hypoxic response of cells. J. Pharmacol. Sci. 108, 79-88
37. Batchu, S. N., Lee, S. B., Samokhvalov, V., Chaudhary, K. R., El-Sikhry, H., Weldon, S. M. and Seubert, J. M. (2012) Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress. Can. J. Physiol. Pharmacol. 90, 811-823
38. Perkins, B. A. and Krolewski, A. S. (2005) Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr. Diab. Rep. 5, 455-463
39. Perkins, B. A., Nelson, R. G., Ostrander, B. E., Blouch, K. L., Krolewski, A. S., Myers, B. D. and Warram, J. H. (2005) Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J. Am. Soc. Nephrol. 16, 1404-1412
40. Saleh, M. A., Boesen, E. I., Pollock, J. S., Savin, V. J. and Pollock, D. M. (2011) Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocininduced rat model of diabetes. Diabetologia 54, 979-988
41. Saleh, M. A., Pollock, J. S. and Pollock, D. M. (2011) Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. J. Pharmacol. Exp. Ther. 338, 263-270
42. Luo, P., Zhou, Y., Chang, H. H., Zhang, J., Seki, T., Wang, C. Y., Inscho, E. W. and Wang, M. H. (2009) Glomerular 20-HETE, EETs, and TGF-β1 in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 296, F556-F563
43. Dahly-Vernon, A. J., Sharma, M., McCarthy, E. T., Savin, V. J., Ledbetter, S. R. and Roman, R. J. (2005) Transforming growth factor-β, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 45, 643-648
44. Zhu, Y., Usui, H. K. and Sharma, K. (2007) Regulation of transforming growth factor β in diabetic nephropathy: implications for treatment. Semin. Nephrol. 27, 153-160
45. Kelly, D. J., Zhang, Y., Connelly, K., Cox, A. J., Martin, J., Krum, H. and Gilbert, R. E. (2007) Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 293, H2860-H2869
46. Daniel, C., Schaub, K., Amann, K., Lawler, J. and Hugo, C. (2007) Thrombospondin-1 is an endogenous activator of TGF-β in experimental diabetic nephropathy in vivo. Diabetes 56, 2982-2989
47. Hughson, A., Bromberg, I., Johnson, B., Quataert, S., Jospe, N. and Fowell, D. J. (2011) Uncoupling of proliferation and cytokines from suppression within the CD4+ CD25+ Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes. Diabetes 60, 2125-2133